Abstract:Background Despite the obvious advantages of metagenomic next-generation sequencing (mNGS) in etiological diagnosis of various infectious diseases, there are few reports on etiological diagnosis of suspected thoracic and abdominal infections in patients with end-stage liver disease (ESLD). Methods Seventy-three ESLD patients were enrolled from January 2019 to May 2021 due to suspected complicated thoracic and abdominal infections with poor response to empirical anti-infective treatment. Pleural effusion and ascites samples of these patients were collected for mNGS detection and conventional pathogen culture. The application value of mNGS in etiological diagnosis of thoracic and abdominal infections in ESLD patients was finally evaluated. Results A total of 96 pathogens were detected using mNGS method, including 47 bacteria, 32 viruses, 14 fungi, 2 Mycobacterium tuberculosis , and 1 parasite. The positive rate of mNGS reached 42.5%, which was significantly higher than that of conventional culture method (21.9%) (p = 0.008). Considering neutrophil counts, the overall positive rate of bacteria detection of both methods in Polymorphonuclear Neutrophils (PMN) ≥250/mm 3 group was 64.3% and in PMN <250/mm 3 group was 23.7%. Compared with the final clinical diagnosis, the agreement rate of mNGS in patients with positive bacteria detection and with suspected positive bacteria detection was 78.6% (11/14) and 44.4% (8/18), respectively. In addition, the agreement rate of mNGS was 66.7% (4/6, respectively) in patients with positive and suspected fungal detection. Interestingly, of the 11 patients with fungal detection, 5 had alcoholic liver disease, accounting for 45.5% of all patients with alcoholic liver disease. We also detected 32 strains of viruses using mNGS, mainly cytomegalovirus (62.5%). Conclusions The mNGS method is a useful supplement to conventional culture methods, which performs a higher positive rate, higher sensitivity, and broader pathogen spectrum, especially for rare pathogens and those difficult to culture. For ESLD patients, mNGS has great prospects in early etiological diagnosis of thoracic and abdominal infections. In addition, the cutoff values for the diagnosis of bacterial infection (PMN ≥250/mm 3 ) in the thoracic and abdominal cavities may need to be redefined.

[Expert consensus on diagnosis and treatment of end-stage liver disease complicated with infections].

Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections

[Research Advances in Diagnosis and Treatment of Liver Failure in 2016].

Progress on Diagnosis and Treatment of Refractoryascites in Patients with Hepatic Failure

Interobserver Agreement for Classifying Infections in Patients with Decompensated Cirrhosis Based on Centers for Disease Control and Prevention Criteria

Microbial Infections As A Trigger For Acute-Onchronic Liver Failure: A Review

Consensus on the Diagnosis and Treatment of Cholestatic Liver Diseases (2015, China)

[Infections and liver cirrhosis]

Chinese Consensus on Clinical Diagnosis and Therapy of Liver Cirrhosis

Chinese consensus on the management of liver cirrhosis

Expert Consensus on Perioperative Management of Liver Transplantation in Adults with Acute-on-chronic Liver Failure

Trends of Mortality in End-Stage Liver Disease — China, 2008–2020

Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai)

Characteristics and diagnosis of concurrent infections in patients with acute-on-chronic liver failure

Infectious Microecology in Liver Disease

End-Stage Liver Disease Comorbidities in Patients Awaiting Transplantation: Identification and Impact on Liver Transplant Survival

Application of mNGS in the Etiological Diagnosis of Thoracic and Abdominal Infection in Patients With End-Stage Liver Disease

Protolized diagnosis and treatment in severe infection

Expert consensus on management of metabolic disease in Chinese liver transplant recipients

Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality.

Shanghai International Consensus on Diagnosis and Comprehensive Treatment of Colorectal Liver Metastases (version 2019)